What's breaking now, across thousands of outlets.
Sun Pharma Q2 Results: Revenue from operations rose 12% YoY to Rs 16,199 crore from Rs 14,478 crore in Q2 of last financial year, supported by strong growth in its domestic formulations business and emerging markets.
We haven't written up this one. The Economic Times - Top News has the full story — the link below goes straight to it.
It’s been a breakout week for Danish biotech Genmab A/S.
German preliminary Q3 Gross Domestic Product (GDP) data arrives at 0.2%, Federal Statistics Office of Germany showed. The growth rate was higher than 0.1% estimates, but slower than 0.3% in the…
Tantalizers Plc nearly doubled its nine-month profit in 2026, as stronger sales, improved gross margins and lower administrative expenses helped
Factors like inflation, interest rates, A.I. and the war with Iran are far more important, our columnist says.
Highlights(1) Delivered strong third-quarter 2026 results, reflecting continued productivity improvements and disciplined execution.
